REPRIEVE Site Newsletters

covid

March 9 | 2020

Featured this issue: • REPRIEVE In the Context of COVID-19: As this is a rapidly evolving situation, please continue to direct all COVID-related questions to the core team at actg.corea5332@fstrf.org• Also featured this issue: FAQ on chest pain • Instructions on Lab Query Responses • Who's Who on REPRIEVE: Lab Techs!

03/09/2020 | PDF

Site Newsletter Archive

Latest Tweets

reprievetrial @reprievetrial
REPRIEVE Trial  @reprievetrial
Mar 12
Want to learn how #REPRIEVE became the largest randomized placebo-controlled clinical trial in #HIV and #CVD to dat… https://t.co/iGafEbXsPB
reply retweet favorite
REPRIEVE Trial  @reprievetrial
Feb 10
#DYK people with HIV are up to twice as likely to develop heart disease, including heart attack and stroke, compare… https://t.co/DUp9Xlr7wG
reply retweet favorite
Load More...